Covid-19 roundup: Mod­er­na gets Swiss boost­er OK; Bi­va­lent shots ex­pect US EUA sans com­plete in-hu­man da­ta — re­port

Af­ter Mod­er­na’s bi­va­lent Omi­cron boost­er first got au­tho­rized in the UK, it was on­ly a mat­ter of time be­fore oth­er coun­tries fol­lowed suit. We now know the next coun­try to sign off on it: Switzer­land.

Mod­er­na put out word Mon­day that the reg­u­la­to­ry agency Swissmedic gave a tem­po­rary thumbs up to the mR­NA be­he­moth’s bi­va­lent boost­er vac­cine, mR­NA-1273.214.

Per a press re­lease, the boost­er is on­ly au­tho­rized for adults. Half of the 50 µg vac­cine tar­gets the orig­i­nal virus strain, while the oth­er half tar­gets Omi­cron BA.1.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER